| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |